Caribou Biosciences, Inc. (CRBU) Tops Q3 EPS by 30c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.12), $0.30 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $23.66 million versus the consensus estimate of $3.15 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)